| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |